The primary goal of the recently renamed Functional Genomics and Microbiome Core (Core C) is to enhance research programs in infection and injury states affecting the mammalian intestine and liver by providing genomics and metagenomics expertise and resources. In this Core, we utilize advanced technology in mammalian and microbial genomics to support ongoing and innovative research to prevent and cure digestive diseases. This Core enables investigators to posit research questions related to gene expression, functional genomics and molecular mechanisms by utilizing the tools of microarrays, deep nucleic acid sequencing (microbial and mammalian), nucleic acid amplification, protein profiling, and bioinformatics. PCR based analyses of gene expression and splicing, DNA mutation/SNP detection, and gene pathway analyses ofthe mammalian metagenome (microbe and man) will be fostered by this Core as a platform for gastrointestinal and hepatic systems biology. Our mission is to provide a full service resource from experimental design to consultations about specimen processing, robust data analysis pipelines, and biostatistical support. In summary, we have created a fully integrated genomic analysis platform for investigators studying digestive diseases.
This Core provides help with complex molecular technologies such as gene expression profiling and genomic microarray analyses, complex protein bead assays, metagenomic sequencing and microbiome analyses needed by DDC members.
|Chen, Deliang; Oezguen, Numan; Urvil, Petri et al. (2016) Regulation of protein-ligand binding affinity by hydrogen bond pairing. Sci Adv 2:e1501240|
|Chumpitazi, Bruno P; Weidler, Erica M; Shulman, Robert J (2016) Lactulose Breath Test Gas Production in Childhood IBS is Associated with Intestinal Transit and Bowel Movement Frequency. J Pediatr Gastroenterol Nutr :|
|Mayo, Sara A; Song, Ye K; Cruz, Melissa R et al. (2016) Indomethacin injury to the rat small intestine is dependent upon biliary secretion and is associated with overgrowth of enterococci. Physiol Rep 4:|
|Graham, David Y; Dore, Maria Pina (2016) Helicobacter pylori therapy: a paradigm shift. Expert Rev Anti Infect Ther 14:577-85|
|Ross, CanÃ¡ L; Spinler, Jennifer K; Savidge, Tor C (2016) Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection. Anaerobe 41:37-43|
|Georgescu, Maria-Magdalena; Gagea, Mihai; Cote, Gilbert (2016) NHERF1/EBP50 Suppresses Wnt-Î²-Catenin Pathway-Driven Intestinal Neoplasia. Neoplasia 18:512-23|
|Spinler, Jennifer K; Ross, CanÃ¡ L; Savidge, Tor C (2016) Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for? Anaerobe 41:51-57|
|Wang, Yaohong; George, Sudeep P; Roy, Swati et al. (2016) Both the anti- and pro-apoptotic functions of villin regulate cell turnover and intestinal homeostasis. Sci Rep 6:35491|
|Meadows, A; Lee, J H; Wu, C-S et al. (2016) Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity. Int J Obes (Lond) 40:417-24|
|Khan, Anam; Tansel, Aylin; White, Donna L et al. (2016) Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic LiverÂ Disease: A Systematic Review. Clin Gastroenterol Hepatol 14:191-202.e1-4; quiz e20|
Showing the most recent 10 out of 939 publications